Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis.
about
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisImmune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β-catenin inhibition and increased Wnt5a/b interaction.Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis.Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.Interleukin-33 potentiates bleomycin-induced lung injury.Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis and a role for autoimmunity.Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles.Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling.Transcriptomic evidence of immune activation in macroscopically normal-appearing and scarred lung tissues in idiopathic pulmonary fibrosis.Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2.Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis.
P2860
Q27316615-186DE41B-19A3-47A3-9200-58CADDDB6996Q36012118-D726B35F-4A26-450E-9A46-2FA30B691A82Q36773752-8F34FA8E-FBC1-4CE9-9AD3-A51BFCA898B2Q36976599-C5EE5DED-EEBE-4364-93EA-76486B6A2AC1Q37420861-D87A0475-F0CA-4B03-8188-D338FB8ED084Q37596499-0029CA1C-37DC-4B97-B294-2EEEE5D25939Q38367113-C9D26588-85AE-4314-A5DE-006607290A9CQ38737879-6F464868-C870-46DB-99C5-B382C9BC5B0BQ42479603-949DD71F-6133-4C04-AD2D-CD1046074C36Q47113769-3A120CA6-265D-49ED-B498-A4F1242D04E5Q47641806-97ECE2C0-D3EB-42D9-8854-CBA792227DF7Q47656873-0B57C033-2179-44C8-B4E2-61C5B74C5CA6Q49917965-DC72EAAE-26DB-4853-B6E9-5EA67D7AEC37Q51233185-8A165896-2716-4882-83B3-27C8115E654BQ52332667-C32F798D-DA54-42EF-B940-DAE969E0EA7DQ55009120-579B476F-054D-4C13-BB50-30DD88401A38
P2860
Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@ast
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@en
type
label
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@ast
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@en
prefLabel
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@ast
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@en
P2093
P2860
P356
P1476
Lymphocyte aggregates persist ...... idiopathic pulmonary fibrosis.
@en
P2093
Aldo T Iacono
Allen P Burke
E James Britt
Irina G Luzina
Jeffrey R Galvin
Nevins W Todd
Rachel G Scheraga
Sergei P Atamas
P2860
P356
10.2147/JIR.S40673
P407
P577
2013-03-27T00:00:00Z